Drug Approval | April 07, 2023
Zydus receives final approval from the USFDA for Carbidopa and Levodopa Tablets
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Acetazolamide is used to treat glaucoma
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
The company will be submitting the responses to US FDA observations within stipulated timeline
Subscribe To Our Newsletter & Stay Updated
